Compare ARK Genomic Revolution ETF (ARKG) vs Electronic Arts Inc. (EA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Electronic Arts Inc. — how do they compare? ARK Genomic Revolution ETF trades at $41, while Electronic Arts Inc. trades at $208.38 (market cap $51.76B). The key difference: Electronic Arts Inc. pays a 0.37% dividend while ARK Genomic Revolution ETF pays none, and Electronic Arts Inc. is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | EA | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $206.56 |
52-Week Low | $23.09 | $147.79 |
Market Cap | — | $51.76B |
Enterprise Value | — | $50.33B |
Dividend Yield | — | 0.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Electronic Arts (EA) trades at $206.41, showing minimal daily movement (-0.07%). The stock presents a mixed fundamental picture with strong profitability metrics including 78.97% gross margins and 11.78% net income margins, though valuation ratios appear elevated with a P/E of 58.81. Recent earnings performance has been inconsistent with two misses and one beat in the last four quarters. Technical indicators suggest a bullish trend with the current price near pivot point resistance at $206.
The outlook remains cautiously optimistic given strong analyst support (43.94% buy ratings) and recent game launches, but investors face valuation concerns and earnings volatility risks. The potential $55 billion Saudi acquisition bid adds significant event risk, while the company's advertising platform expansion provides growth opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Electronic Arts Inc.
EA is one of the world's largest third-party video game publishers and has transitioned from a console-based video game publisher to the one of the largest publishers on consoles, PC, and mobile. The firm owns number of large franchises, including Madden, FIFA, Battlefield, Apex Legends, Mass Effect, Dragon's Age, and Need for Speed.
Read more on EA →
